Stay updated on Study of bb2121 in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Study of bb2121 in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of bb2121 in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for the Phase 1 bb2121 trial in relapsed or refractory multiple myeloma is displayed, with details on the treatment, eligibility, study outcomes, and participating locations.
    Difference
    50%
    Check dated 2026-11-10T07:17:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-11-03T06:36:26.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-27T07:50:00.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-20T08:28:30.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T10:49:43.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A 403 Forbidden error page now appears, replacing the study record content. This indicates an access restriction to the study information on the page.
    Difference
    17%
    Check dated 2026-09-22T12:32:01.000Z thumbnail image

Stay in the know with updates to Study of bb2121 in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of bb2121 in Multiple Myeloma Clinical Trial page.